Suchergebnisse - "Mekinian, Arsène"

PubPharm (5)

1

Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome : a retrospective multicenter study

enthalten in: Blood | 2022

von Heiblig, M. | Ferrada, M. | Koster, M. | +22

CommentIn: Blood. 2022 Aug 25;140(8):807-808. - PMID 36006674

2

Patients with refractory catastrophic antiphospholipid syndrome respond inconsistently to eculizumab

enthalten in: Blood | 2020

von Yelnik, C. | Miranda, S. | Mékinian, A. | +9

CommentIn: Br J Haematol. 2022 Jan;196(2):e12-e14. - PMID 34396515

3

Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19

enthalten in: Blood | 2020

von Hueso, T. | Pouderoux, C. | Péré, H. | +34

CommentIn: Blood. 2020 Nov 12;136(20):2245-2246. - PMID 33180920

4

Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema

enthalten in: Blood | 2020

von Mahévas, T. | Arnulf, B. | Bouaziz, J. | +43

CommentIn: Blood. 2020 Apr 2;135(14):1074-1076. - PMID 32243515

5

A case-control study to assess the risk of immune thrombocytopenia associated with vaccines

enthalten in: Blood | 2012

von Grimaldi-Bensouda, L. | Michel, M. | Aubrun, E. | +29

1
[1]